KEGG: syn:sll1685
STRING: 1148.SYNGTS_0210
The recombinant sll1685 protein should be stored according to specific guidelines to maintain its stability and biological activity. Upon receipt, the protein should be stored at -20°C/-80°C, with aliquoting being necessary for multiple use. For working aliquots, storage at 4°C for up to one week is recommended. It is important to avoid repeated freeze-thaw cycles as this can significantly compromise protein integrity .
For long-term storage, the protein can be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, with the addition of 5-50% glycerol (final concentration) before aliquoting and storing at -20°C/-80°C. The standard storage buffer typically consists of a Tris/PBS-based buffer with 6% Trehalose at pH 8.0 .
E. coli is the most commonly used expression system for the production of recombinant sll1685 protein. This heterologous expression system has been optimized for the production of the full-length (1-393 amino acids) protein with various fusion tags, particularly the N-terminal His-tag which facilitates purification .
When expressing recombinant proteins in prokaryotic systems like E. coli, several factors need to be considered:
Selection of appropriate E. coli strain (BL21, Rosetta, etc.)
Optimization of induction conditions (IPTG concentration, temperature, duration)
Codon optimization for the target gene
Selection of appropriate vector with compatible promoter and fusion tags
The expression system selection should be based on the specific research requirements, including the need for post-translational modifications, protein solubility, and downstream applications .
Optimization of recombinant sll1685 expression can be achieved using Design of Experiments (DoE), a statistical approach that allows for systematic investigation of multiple factors simultaneously. The typical DoE workflow for optimizing recombinant protein production involves:
Define objectives and select factors, levels, and responses
Identify process variables and set their levels (high, low, and sometimes mid-point)
Select an appropriate experimental design
Build a mathematical model
Analyze and visualize response data
Perform further optimization with selected influential factors
For recombinant sll1685 expression, a two-level factorial design could be implemented to investigate 9 key factors:
| Factor | Low Level (-1) | High Level (+1) |
|---|---|---|
| Temperature | 25°C | 37°C |
| Induction time | 4 hours | 16 hours |
| IPTG concentration | 0.1 mM | 1.0 mM |
| Media composition | Minimal | Rich |
| OD600 at induction | 0.6 | 1.2 |
| Post-induction temperature | 16°C | 30°C |
| Shaking speed | 150 rpm | 250 rpm |
| pH | 6.5 | 7.5 |
| Antibiotic concentration | 50 μg/mL | 100 μg/mL |
After identifying the most influential factors through a screening design like Plackett-Burman Design (PBD), further optimization can be conducted using Response Surface Methodology (RSM) approaches such as Central Composite Design (CCD) or Box-Behnken Design (BBD). These approaches have been shown to increase recombinant protein yields by 3-5 fold in similar systems .
Comprehensive characterization of recombinant sll1685 requires multiple analytical techniques:
Primary structure analysis:
Mass spectrometry (MS) for exact molecular weight determination
N-terminal sequencing for confirmation of the starting amino acid
Peptide mapping using LC-MS/MS after enzymatic digestion
Secondary and tertiary structure analysis:
Circular dichroism (CD) spectroscopy for secondary structure content
Fourier-transform infrared spectroscopy (FTIR)
Nuclear magnetic resonance (NMR) for detailed structural information
X-ray crystallography for high-resolution 3D structure
Purity assessment:
Functional characterization:
Activity assays specific to CemA-like proteins
Binding assays to identify interaction partners
Stability assessments under various conditions
| Analytical Method | Parameter Measured | Result |
|---|---|---|
| SDS-PAGE | Purity | >90% |
| Mass Spectrometry | Molecular Weight | ~44 kDa (with His-tag) |
| CD Spectroscopy | Secondary Structure | % α-helix, % β-sheet |
| SEC-MALS | Oligomeric State | Monomer/Dimer ratio |
The combination of these techniques provides a comprehensive profile of the recombinant protein, ensuring its identity, purity, and structural integrity before proceeding with functional studies .
Based on gene expression data, sll1685 shows differential expression patterns under iron deprivation conditions in Synechocystis sp. Analysis of transcriptomic data reveals complex expression patterns in response to iron limitation:
| Gene ID | Gene Name | Expression Value (Log2 Fold Change) |
|---|---|---|
| sll1685 | CemA-like protein | Varies by condition and time point |
The expression pattern suggests that sll1685 may be involved in cellular adaptation to iron limitation. To further investigate this response, researchers should consider:
Time-course experiments: Monitor expression changes at multiple time points after initiating iron deprivation
Comparative proteomics: Compare protein levels with transcript levels to identify post-transcriptional regulation
Knockout/complementation studies: Create sll1685 mutants to assess phenotypic changes under iron limitation
Protein interaction studies: Identify potential interaction partners that may form functional complexes during stress response
The analysis of contradictory expression data across different studies requires careful consideration of experimental conditions, including the severity and duration of iron limitation, light conditions, and other environmental factors .
To investigate protein-protein interactions involving recombinant sll1685, multiple complementary approaches should be employed:
In vitro approaches:
Pull-down assays using His-tagged sll1685 as bait
Surface plasmon resonance (SPR) for real-time binding kinetics
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Analytical ultracentrifugation to determine complex stoichiometry
In vivo approaches:
Bacterial two-hybrid system adapted for cyanobacterial proteins
Co-immunoprecipitation from Synechocystis lysates
Proximity labeling techniques such as BioID or APEX2
Fluorescence resonance energy transfer (FRET) for living cell studies
Computational approaches:
Protein-protein interaction prediction algorithms
Molecular docking simulations
Sequence co-evolution analysis
A systematic approach would first identify potential interaction partners using high-throughput methods, followed by validation with targeted experiments. For instance, a pull-down assay using His-tagged sll1685 could identify candidate interactors that would then be confirmed using orthogonal methods such as SPR or ITC.
When documenting interaction studies, present data in well-organized tables:
| Interaction Partner | Detection Method | Binding Affinity (Kd) | Interaction Domain |
|---|---|---|---|
| Protein X | Pull-down / MS | N/A | N-terminal domain |
| Protein Y | SPR | 5.3 μM | C-terminal domain |
| Protein Z | ITC | 2.1 μM | Middle domain |
This multi-method approach provides robust evidence for genuine protein-protein interactions and helps characterize their functional significance .
Determining the subcellular localization of sll1685 requires a multi-faceted experimental approach:
Computational prediction:
Use algorithms specific for bacterial proteins to predict transmembrane domains, signal peptides, and localization signals
Tools such as TMHMM, SignalP, and PSORT-B can provide initial predictions
Fluorescent protein fusion:
Generate C- and N-terminal GFP fusions of sll1685
Express in Synechocystis under native or inducible promoters
Visualize using confocal microscopy with appropriate markers for different cellular compartments
Subcellular fractionation:
Isolate different cellular fractions (cytoplasmic, membrane, thylakoid, etc.)
Detect sll1685 using Western blotting with specific antibodies
Include controls for each fraction (known proteins with established localizations)
Immunogold electron microscopy:
Use antibodies against sll1685 with gold-conjugated secondary antibodies
Visualize precise localization at nanometer resolution
The experimental design should include appropriate controls and validation steps. For example, when using GFP fusions, it is important to verify that the fusion protein retains functionality and that the GFP tag does not interfere with localization signals.
Results can be presented in a comprehensive table format:
| Method | Predicted/Observed Localization | Confidence Level | Comments |
|---|---|---|---|
| TMHMM prediction | 5 transmembrane domains | High | Hydrophobic regions at positions X-Y |
| GFP fusion (C-terminal) | Plasma membrane | High | Co-localization with plasma membrane marker |
| GFP fusion (N-terminal) | Disrupted localization | Medium | Potential N-terminal signal sequence |
| Subcellular fractionation | Enriched in membrane fraction | High | Detected by Western blot |
| Immunogold EM | Plasma membrane | Very high | Precise localization at cell periphery |
When faced with contradictory data regarding sll1685 function, a systematic approach to analysis and interpretation is essential:
Examine experimental conditions:
Compare expression systems (E. coli strains, growth conditions)
Assess protein preparation methods (purification tags, buffer compositions)
Review experimental parameters (temperature, pH, salt concentration)
Evaluate methodological differences:
Identify variations in assay formats
Compare detection methods and their sensitivities
Consider the impact of protein modifications or tag positions
Conduct statistical analysis:
Perform meta-analysis of multiple datasets when available
Apply appropriate statistical tests to determine significance
Use power analysis to ensure adequate sample sizes
Design reconciliation experiments:
Create experiments specifically designed to address the contradictions
Include side-by-side comparisons of methods
Introduce controlled variables to isolate sources of discrepancy
When documenting contradictory findings, use a structured approach to present the conflicting data:
| Study | Key Finding | Experimental Conditions | Potential Explanation for Discrepancy |
|---|---|---|---|
| Study A | sll1685 upregulated during iron deprivation | 3-day iron starvation, high light | Extended response to severe stress |
| Study B | sll1685 downregulated during iron deprivation | 12-hour iron limitation, standard light | Initial stress response differs |
| Current study | Biphasic response | Time course over 7 days | Captures both early and late responses |
This approach not only acknowledges contradictions but transforms them into opportunities for deeper understanding of the protein's function under different conditions or contexts .
Investigating the structure-function relationship of sll1685 requires an integrated approach combining structural biology, molecular biology, and biochemical techniques:
Structural characterization:
X-ray crystallography or cryo-EM for high-resolution structure
NMR spectroscopy for dynamic regions and ligand binding
Homology modeling based on related proteins if experimental structures are unavailable
Domain mapping:
Generate truncation constructs to isolate functional domains
Express and purify individual domains for functional testing
Create chimeric proteins with domains from related CemA-like proteins
Site-directed mutagenesis:
Identify conserved residues through sequence alignment
Design mutations of key residues (conservative and non-conservative)
Generate comprehensive alanine scanning library for systematic analysis
Functional assays:
Develop quantitative assays for specific functions
Test wild-type and mutant proteins under identical conditions
Correlate structural features with functional outcomes
The mutational analysis data can be presented in a comprehensive table format:
| Mutation | Structural Location | Functional Effect | Conservation | Interpretation |
|---|---|---|---|---|
| K15A | N-terminal domain | 85% activity | Highly conserved | Not essential but contributes |
| D120A | Central domain | <5% activity | Invariant | Critical catalytic residue |
| R250A | C-terminal domain | 50% activity | Variable | Modulatory role |
| Triple mutant (KDR→AAA) | Multiple domains | No activity | Mixed | Synergistic effect |
This systematic approach allows for mapping of functional sites and establishing the molecular basis for sll1685 activity, providing insights into both the specific protein and the broader CemA-like protein family .
Optimizing the purification of recombinant His-tagged sll1685 requires careful consideration of multiple factors:
Lysis buffer optimization:
Test different buffer compositions (Tris, phosphate, HEPES)
Optimize pH range (typically 7.5-8.5 for His-tagged proteins)
Evaluate detergent types and concentrations if membrane-associated
Include appropriate protease inhibitors
Immobilized metal affinity chromatography (IMAC) conditions:
Compare Ni-NTA, Co-NTA, and other metal resins
Optimize imidazole concentrations for binding, washing, and elution
Evaluate flow rates and contact times
Consider on-column refolding if protein forms inclusion bodies
Secondary purification steps:
Size exclusion chromatography for final polishing
Ion exchange chromatography to remove contaminants
Affinity tag removal and subsequent separation
Quality assessment:
A sample purification optimization table:
| Parameter | Condition 1 | Condition 2 | Condition 3 | Optimal |
|---|---|---|---|---|
| Lysis buffer | PBS, pH 7.4 | Tris 50mM, pH 8.0 | HEPES 50mM, pH 8.0 | Tris 50mM, pH 8.0 |
| Detergent | None | 0.1% Triton X-100 | 1% NP-40 | 0.1% Triton X-100 |
| IMAC resin | Ni-NTA | Co-NTA | TALON | Ni-NTA |
| Wash imidazole | 10 mM | 20 mM | 30 mM | 20 mM |
| Elution imidazole | 250 mM | 300 mM | 500 mM | 300 mM |
| Final yield | 3 mg/L | 5 mg/L | 2 mg/L | 5 mg/L |
| Purity | 85% | 92% | 95% | >90% |
The purified protein should be rapidly aliquoted and stored with 50% glycerol at -20°C or -80°C to avoid repeated freeze-thaw cycles, which can significantly affect protein stability and activity .
Developing a quantitative assay for sll1685 activity requires first understanding its putative function as a CemA-like protein. Based on the available information, several approaches can be considered:
Membrane transport/ion flux assays:
Reconstitute purified sll1685 into liposomes
Measure ion flux using fluorescent dyes or electrochemical methods
Monitor pH changes associated with transport activity
Use radio-labeled substrates to track movement across membranes
Binding assays:
Microscale thermophoresis (MST) to measure binding to potential ligands
Surface plasmon resonance (SPR) for real-time binding kinetics
Fluorescence anisotropy for interaction with small molecules
Isothermal titration calorimetry (ITC) for thermodynamic parameters
Enzyme-coupled assays (if enzymatic activity is suspected):
Spectrophotometric assays linked to NAD(P)H production/consumption
Coupled enzyme systems that amplify signal detection
Colorimetric assays for potential products
In vivo functional complementation:
Generate knockout strains of sll1685 in Synechocystis
Complement with wild-type and mutant versions
Measure restoration of phenotype quantitatively
For assay development, a systematic optimization approach should be documented:
| Assay Parameter | Optimization Range | Optimal Condition | Impact on Assay |
|---|---|---|---|
| Buffer composition | HEPES, Tris, Phosphate | HEPES 50mM | Minimal background |
| pH | 6.5-8.5 | 7.5 | Maximum signal:noise |
| Temperature | 25-40°C | 30°C | Stable baseline |
| Substrate concentration | 1-100 μM | 25 μM | Below saturation |
| Detection method | Absorbance, fluorescence | Fluorescence | 10-fold sensitivity increase |
| Linear range | 0.1-10 μM | 0.5-5 μM | R² > 0.99 |
| Z-factor | 0.5-0.8 | 0.7 | Excellent assay quality |
The final assay should be validated with positive and negative controls, dose-response curves, and statistical analysis to ensure reproducibility and reliability for characterizing both wild-type sll1685 and any mutant variants .